SCHEMBL5694476

SCHEMBL5694476

NC(=O)c1cccc(F)c1-c1cccc(C(F)(F)F)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 2/20 0.54
KIF11 P52732 1/20 0.49
KDM4E B2RXH2 1/20 0.47
CNR2 P34972 1/20 0.47
AKR1C3 P42330 1/20 0.46
AKR1C2 P52895 1/20 0.46
RORC P51449 2/20 0.46
RORB Q92753 2/20 0.46
IL2 P60568 1/20 0.45
JAK2 O60674 1/20 0.44
MAPT P10636 1/20 0.44
SLC1A3 P43003 1/20 0.44
SLC1A2 P43004 1/20 0.44
SLC1A1 P43005 1/20 0.44
ADORA1 P30542 1/20 0.43
SLC9A1 P19634 1/20 0.43
PLG P00747 1/20 0.43
PLAU P00749 1/20 0.43
PLAT P00750 1/20 0.43
CES2 O00748 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4724483 0.91 PARP1 (0.59) PARP1KIF11KDM4ECNR2RORC
SCHEMBL16127491 0.81 IKBKB (0.53) CNR2AKR1C3AKR1C2IL2MAPT
Trifluoroacetic Acid SCHEMBL31255312 0.79 BCAT2 (0.46) PARP1KDM4EMAPTCES2
SCHEMBL30272163 0.79 RORB (0.66) PARP1KIF11KDM4ECNR2RORC
SCHEMBL4683411 0.79 RORB (0.66) PARP1KIF11KDM4ECNR2RORC
SCHEMBL30411754 0.79 GPR52 (0.46) PARP1KIF11KDM4ECNR2AKR1C3
SCHEMBL352877 0.78 PARP1 (0.50) PARP1KIF11KDM4ECNR2AKR1C3
SCHEMBL3455274 0.76 PLG (0.54) PARP1KIF11KDM4ECNR2JAK2
SCHEMBL5964891 0.75 PARP1 (0.56) PARP1KIF11KDM4ERORCRORB
SCHEMBL27922027 0.75 AURKA (0.49) PARP1KDM4EMAPTCES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1667721-A2 COMBINATIONS OF A VEGF RECEPTOR INHIBITOR WITH OTHER THERAPEUTIC AGENTS Novartis AG (CH) 2006-06-14 EP disclosed
WO-2005027973-A2 COMBINATIONS OF A VEGF RECEPTOR INHIBITOR WITH OTHER THERAPEUTIC AGENTS NOVARTIS AG (CH) 2005-03-31 WO disclosed